© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, BioAge Labs, Inc. (BIOA) shows an Average True Range (ATR) of 1.46 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 679.1K, indicating liquidity. These fundamental metrics provide insight into BIOA's underlying financial health and market activity.
| ATR | 1.46 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 679.1K |
| Avg Vol (10 Days) | 582.97K |
BioAge Labs, Inc. (BIOA) technical indicators as of February 26, 2026: the SMA 20 is 9.72%, SMA 50 at 25.96%, and SMA 200 at 157.35%. The RSI 14 value is 69.63, suggesting its current momentum. These technical analysis signals help assess BIOA's price trends and potential future movements.
| SMA 20 | 9.72% |
| SMA 50 | 25.96% |
| SMA 200 | 157.35% |
| RSI 14 | 69.63 |
BioAge Labs, Inc. (BIOA) stock performance overview as of February 26, 2026: The 52-week high is $24 (currently -7.75% below), and the 52-week low is $2.88 (currently 668.75% above). Over the past year, BIOA's performance is 323.02%, compared to the S&P 500's 10.91% change.
| 52-Week High | 24 |
| 52-Week High Chg | -7.75% |
| 52-Week Low | 2.88 |
| 52-Week Low Chg | +668.75% |
| S&P 500 52-Week Chg | 10.91% |
According to market data, BioAge Labs, Inc. (BIOA) stock's recent performance metrics show that over the last month, BIOA is 73.33%, with a Year-to-Date (YTD) performance of 61.15%. Over the past year, the stock has seen a 323.02% change. These figures summarize BIOA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 23 | 23 | 24 | 24 | 24 | 24 |
| Low | 19.16 | 18.32 | 8.45 | 4.42 | 2.88 | 11.87 |
| Performance | +19.44% | +73.33% | +311.58% | +363.48% | +323.02% | +61.15% |
According to current financial data, BIOA stock's P/E (TTM) ratio is -10.49, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for BIOA, including P/S (134.34), P/B (2.86), and P/FCF (-13.44), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BIOA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -10.49 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 134.34 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 2.86 | 0.16 | 9 | 5.26 |
| P/FCF (TTM) | -13.44 | -6.25 | -253.28 | 30.85 |